Trial Profile
Efficacy of Sofosbuvir and Ribavirin combination therapy in liver transplant recipients with recurrent hepatitis C
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Sofosbuvir (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- 12 May 2016 New trial record
- 17 Apr 2016 Results presented at The International Liver Congress™ 2016.